Beloved, well-read, much-experienced cancer colleagues,
My PSA has gone up quite slowly since being OFF all ADT since 2015-16 clinical trial on Lupron and Apaludimide (I had heart attack and a TIA then- my oncologist has not urged me to go back on ADT since). My PSA is now just under 2.7 but was 1.4 in July, 2020, so the doubling time has been slow. However, my first PSMA scan in January showed 9-10 tiny nodal mets from abdomen up to my neck.
I see my oncologist in a few days, and if Medicare will cover it, I am thinking I’ll be going on degarelix (Firmagon) supplemented by darolutamide (Nubeqa), both chosen because of past cardiac concerns (presumably heart and brain-safer than Lupron and Apalutamide).
Do you guys think this is a good plan? And if I start, should I plan to just stay with it? It’s not as aggressive as the triple plans some recommend, but my doubling time is slow and am only now seeing mets, all of which are in lymph nodes…
Thanks